Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Techne (TECH) Short-term Investments (2016 - 2025)

Bio-Techne (TECH) has 15 years of Short-term Investments data on record, last reported at $3.2 million in Q4 2024.

  • For Q4 2024, Short-term Investments changed N/A year-over-year to $3.2 million; the TTM value through Dec 2024 reached $3.2 million, changed N/A, while the annual FY2024 figure was $1.1 million, 93.64% down from the prior year.
  • Short-term Investments reached $3.2 million in Q4 2024 per TECH's latest filing, down from $6.7 million in the prior quarter.
  • Across five years, Short-term Investments topped out at $124.3 million in Q2 2020 and bottomed at $1.1 million in Q2 2024.
  • Average Short-term Investments over 5 years is $52.0 million, with a median of $37.8 million recorded in 2022.
  • Peak YoY movement for Short-term Investments: skyrocketed 129.37% in 2022, then tumbled 93.64% in 2024.
  • A 5-year view of Short-term Investments shows it stood at $117.4 million in 2020, then crashed by 42.83% to $67.1 million in 2021, then crashed by 52.22% to $32.1 million in 2022, then tumbled by 45.47% to $17.5 million in 2023, then tumbled by 81.55% to $3.2 million in 2024.
  • Per Business Quant database, its latest 3 readings for Short-term Investments were $3.2 million in Q4 2024, $6.7 million in Q3 2024, and $1.1 million in Q2 2024.